
    
      This is a prospective, multi-center, open-label, randomized, controlled, non-inferiority
      clinical trial designed to evaluate the effectiveness and the safety of the PowerMeTM Midline
      Catheter compared to PIVC in the Chinese population in order to support the product's
      registration in China.
    
  